|
1
|
Winsett R, Stratta RJ, Alloway R, Wicks MN
and Hathaway DK: Immunosuppressant side effect profile does not
differ between organ transplant types. Clin Transplant. 15:46–50.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nankivell BJ, Borrows RJ, Fung CL-S,
O'Connell PJ, Chapman JR and Allen RDM: Calcineurin inhibitor
nephrotoxicity: longitudinal assessment by protocol histology.
Transplantation. 78:557–565. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schweer T, Gwinner W, Scheffner I, Schwarz
A, Haller H and Blume C: High impact of rejection therapy on the
incidence of post-transplant diabetes mellitus after kidney
transplantation. Clin Transplant. 28:512–519. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang S, Herrera O and Lechler RI: New
spectrum of allorecognition pathways: implications for graft
rejection and transplantation tolerance. Curr Opin Immunol.
16:550–557. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yuan X, Paez-Cortez J, Schmitt-Knosalla I,
D'Addio F, Mifarrej B, Donnarumma M, Habicht A, Clarkson MR,
Iacomini J, Glimcher LH, et al: A novel role of CD4 Th17 cells in
mediating cardiac allograft rejection and vasculopathy. J Exp Med.
205:3133–3144. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gorbaxheva V, Fan R, Li X and Valujskikh
A: Interleukin-17 promotes early allograft inflammation. Am J
Pathol. 177:1265–1273. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Itoh S, Nakae S, Axtell RC, Velotta JB,
Kimura N, Kajiwara N, Iwakura Y, Saito H, Adachi H, Steinman L, et
al: IL-17 contributes to the development of chronic rejection in a
murine heart transplant model. J Clin Immunol. 30:235–240. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wood KJ, Bushell A and Hester J:
Regulatory immune cells in transplantation. Nat Rev Immunol.
12:417–430. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Danen EH and Yamada KM: Fibronectin,
integrins, and growth control. J Cell Physiol. 189:1–13. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sashinami H, Takagaki K and Nakane A:
Salmon cartilage proteoglycan modulates cytokine responses to
Escherichia coli in mouse macrophages. Biochem Biophys Res Commun.
351:1005–1010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mitsui T, Sashinami H, Sato F, Kijima H,
Ishiguro Y, Fukuda S, Yoshihara S, Hakamada K and Nakane A: Salmon
cartilage proteoglycan suppresses mouse experimental colitis
through induction of Foxp3+ regulatory T cells. Biochem Biophys Res
Commun. 402:209–215. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sashinami H, Asano K, Yoshimura S, Mori F,
Wakabayashi K and Nakane A: Salmon proteoglycan suppresses
progression of mouse experimental autoimmune encephalomyelitis via
regulation of Th17 and Foxp3+ regulatory T cells. Life Sci.
91:1263–1269. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoshimura S, Asano K and Nakane A:
Attenuation of collagen-induced arthritis in mice by salmon
proteoglycan. Biomed Res Int. 2014:4064532014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirose S, Asano K and Nakane A:
Attenuation of obesity-induced inflammation in mice orally
administered with salmon cartilage proteoglycan, a prophylactic
agent. Biochem Biophys Res Commun. 484:480–485. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Billingham RE and Medawar PB: The
technique of free skin grafting in mammals. J Exp Biol. 28:385–402.
1951.
|
|
16
|
Ye P, Rodriguez FH, Kanaly S, Stocking KL,
Schurr J, Schwarzenberger P, Oliva P, Huang W, Zhang P, Zhang J, et
al: Requirement of interleukin 17 receptor signaling for lung CXC
chemokine and granulocyte colony-stimulating factor expression,
neutrophil recruitment, and host defense. J Exp Med. 194:519–527.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gaffen SL: An overview of IL-17 function
and signaling. Cytokine. 43:402–407. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mika A and Stepnowski P: Current methods
of the analysis of immunosuppressive agents in clinical materials.
J Pharm Biomed Anal. 127:207–231. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji YD, Aboalela A and Villa A:
Everolimus-associated stomatitis in a patient who had renal
transplant. BMJ Case Rep. 2016:bcr20162175132016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kerperien J, Jeurink PV, Wehkamp T, van
der Veer A, van de Kant HJ, Hofman GA, van Esch EC, Garssen J,
Willemsen LE and Knippels LM: Non-digestible oligosaccharides
modulate intestinal immune activation and suppress cow's milk
allergic symptoms. Pediatr Allergy Immunol. 25:747–754. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yasuda A, Inoue KI, Sanbongi C, Yanagisawa
R, Ichinose T, Yoshikawa T and Takano H: Dietary supplementation
with fructooligosaccharides attenuates airway inflammation related
to house dust mite allergen in mice. Int J Immunopathol Pharmacol.
23:727–735. 2010. View Article : Google Scholar : PubMed/NCBI
|
